by DMCBiotech | Jan 9, 2018 | News
09 January 2018 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a first equity financing led by Capricorn Venture Partners. The company also announced the addition to its Board of Directors of Rob van der Meij,...
by DMCBiotech | Dec 31, 2016 | News
STTR Phase I: Commercialization of Synthetic Metabolic Valves Award Information Agency: National Science Foundation Branch: N/A Contract: 1549624 Agency Tracking Number: 1549624 Amount: $225,000.00 Phase: Phase I Program: STTR Solicitation Topic Code: BT Solicitation...
by DMCBiotech | Dec 23, 2016 | News
Award Abstract #1549624 STTR Phase I: Commercialization of Synthetic Metabolic Valves NSF Org: IIP Div Of Industrial Innovation & Partnersh Initial Amendment Date: December 18, 2015 Latest Amendment Date: December 23, 2016 Award Number: 1549624 Award Instrument:...
by DMCBiotech | May 16, 2016 | News
DOE Announces $10 Million for Innovative Bioenergy Research and Development The U.S. Department of Energy announced up to $10 million in funding for six projects representing innovative technologies and solutions to advance bioenergy development. These projects,...
by DMCBiotech | Mar 18, 2015 | News
Technology simplifies and maximizes chemical production by decoupling microbial growth and product formation processes Duke has licensed technology developed in its engineering research laboratories to a spinoff company looking to help transform carbohydrate...
